Skip to main content
SpringerLink
Log in

Complementary and Alternative Medicine in Neurology

  • Chapter
Alternative Medicine for the Elderly

  • 279 Accesses

Abstract

Neurology certainly has its fair share of incurable illness, inviting complementary and alternative (CAM) therapeutic modalities as a source of succor if not cure. Interestingly, even when help is available, patients continue to seek CAM therapies. This is not the result of dissatisfaction with conventional medicine. Rather, they seek options more “congruent with their values, beliefs, and philosophies”, to provide a more “holistic” approach to life and health [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Astin JA. Why patients use alternative medicine JAMA 1998; 279; 1548–1553

    CAS  Google Scholar 

  2. Schoenen J, Jacquay J, Lenaerts M. Effectiveness of high dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998; 50: 466–470

    Article  PubMed  CAS  Google Scholar 

  3. Gallai V, Sarchielli P, Abbritti G. Red blood cell magnesium levels in migraine patient. Cephalgia 1993; 13: 81–94

    Article  Google Scholar 

  4. Piekert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double blind randomized study. Cephalalgia 1996; 16: 257–263

    Article  Google Scholar 

  5. Murphy JJ, Heptinstall S, Mitchell JR. Randomized double-blind controlled trial of feverfew in migraine prevention. Lancet 1988; 2: 189–192

    Article  PubMed  CAS  Google Scholar 

  6. Vogler BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systemic review. Cephalalgia. 1998; 18: 704–708

    Article  PubMed  CAS  Google Scholar 

  7. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine. 1998; 158: 2200–11

    Article  PubMed  CAS  Google Scholar 

  8. Manias P, et al. Acupuncture in headache: a critical review. Clinical Journal of Pain 2000; 16: 334–9

    Article  PubMed  CAS  Google Scholar 

  9. Melchart D et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalgia 1999; 19: 779–86

    Article  CAS  Google Scholar 

  10. Hesse J et al. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. Journal of Internal Medicine 1994; 235: 451–6

    Article  PubMed  CAS  Google Scholar 

  11. Nelson CF et al. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. Journal of Manipulative and Physiological Therapeutics 1998; 21: 511–19

    PubMed  CAS  Google Scholar 

  12. Bronfort G et al. Efficacy of spinal manipulation for chronic headache: a systematic review. Journal of Manipulative and Physiological Therapeutics 2001; 24: 457–66

    PubMed  CAS  Google Scholar 

  13. Ernst E. Homeopathic prophylaxis of headache and migraine: a systematic review. Journal of Pain and Symptom Management 1999; 18: 353–357

    Article  PubMed  CAS  Google Scholar 

  14. Leone M, et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995 Jun; 15: 224–9

    Article  PubMed  CAS  Google Scholar 

  15. Leone M, et al. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996 Nov; 16: 494–6

    Article  PubMed  CAS  Google Scholar 

  16. Braquet P, et al. Is there a case for PAF antagonists in the treatment of ischemic disease? Trends in Pharmacol Sci 1989; 10: 23–30

    Article  CAS  Google Scholar 

  17. Oyama Y, et al. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(z+)-loaded brain neurons. Brain Res 1994; 635 (1–2): 125–9

    Article  PubMed  CAS  Google Scholar 

  18. Zhang WR, et al. Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurology Research 2000; 22 (5): 517–21

    CAS  Google Scholar 

  19. Clark WM, et al. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 2001; 32 (4): 1000

    Article  PubMed  CAS  Google Scholar 

  20. Sun BL, et al. Effects of Ginkgo biloba extract on somatosensory evoked potential, nitric oxide levels in serum and brain tissue in rats with cerebral vasospasm after subarachnoid hemorrhage. Clin Hemorheol Microcirc 2000; 23 (2–4): 139–44

    PubMed  CAS  Google Scholar 

  21. Backhauss C, Krieglstein J. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 1992; 215: 265–9

    Article  PubMed  CAS  Google Scholar 

  22. Garg RK, et al. A double blind placebo controlled trial of gingko biloba extract in acute cerebral ischemia. J Assoc Physicians India 1995; 43 (11): 760–3

    PubMed  CAS  Google Scholar 

  23. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Annals of Internal Medicine 2000; 133: 420–9

    PubMed  CAS  Google Scholar 

  24. Pruthi S, et al. Vitamin E supplementation in the prevention of coronary heart disease. Mayo Clin Proc 2001; 76 (11): 1131–6

    Article  CAS  Google Scholar 

  25. NIH Consensus Statement 1997; 15: 1–34

    Google Scholar 

  26. Wong AM, et al. Clinical trial of electrical acupuncture on hemiplegic stroke patients. American Journal of Physical Medicine and Rehabilitation 1999; 78: 117–22

    Article  PubMed  CAS  Google Scholar 

  27. Naeser MA, et al. Acupuncture in the treatment of paralysis in chronic and acute stroke patients–improvement correlated with specific CT scan lesion sites. Acupuncture Electrotherapy Research 1994; 19: 227–49

    CAS  Google Scholar 

  28. Johansson K, Lindgren I, Widner H, Wiklund I, Johansson B. Can sensory stimulation improve functional outcome in stroke patients. Neurology 1993; 43: 2189–2192

    Article  PubMed  CAS  Google Scholar 

  29. Johansson BB, et al. Acupuncture and transcutaneous nerve stimulation in stroke rehabilitation: a randomized, controlled trial. Stroke 2001; 32: 707–13

    Article  PubMed  CAS  Google Scholar 

  30. Sze FK, et al. Does acupuncture have additional value to standard post-stroke motor rehabilitation? Stroke 2002; 33 (1): 186–94

    Article  PubMed  Google Scholar 

  31. Chang CE Hyperbaric oxygen therapy for treatment of post-ischemic stroke in adult rats. Exp Neurol 2000; 166 (2): 298–306

    Article  PubMed  CAS  Google Scholar 

  32. Nighoghossian N, et al. Hyperbaric oxygen in the treatment of acute ischemic stroke. Stroke 1995; 26 (8): 1369

    Article  PubMed  CAS  Google Scholar 

  33. Rajendran et al. The use of alternative therapies by patients with Parkinson’s disease. Neurology 2001; 57: 790–794

    Article  PubMed  CAS  Google Scholar 

  34. Roghani M, et al. Neuroprotective effect of vitamin E on the early model of Parkinson’s disease in rat: behavioral and histochemical evidence. Brain Res 2001; 892 (1): 211–7

    CAS  Google Scholar 

  35. Fahn S. An open trial of high-dosage antioxidants in early Parkinson’s disease. Am J Clin Nutr 1991; 53 (1 Suppl): 380S - 382S

    PubMed  CAS  Google Scholar 

  36. Nicolletti G, et al. Plasma levels of vitamin E in Parkinson’s disease. Arch Gerontol Geriatr 2001; 33: 7–12

    Article  Google Scholar 

  37. Shults CW, et al. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinson and nonparkinson subjects. Annals of Neurology 1997; 42 (2): 261–4

    Article  PubMed  CAS  Google Scholar 

  38. Shults CW, et al. Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. Neurology 1998; 50: 793–5

    Article  PubMed  CAS  Google Scholar 

  39. Rabey JM, et al. Broad bean (Vicia faba) consumption and Parkinson’s disease. Adv Neurol. 1993; 60: 681–4

    PubMed  CAS  Google Scholar 

  40. Apaydin H. Broad bean (Vicia faba)-a natural source of L-dopa-prolongs “on” periods in patients with Parkinson’s disease who have “on-off” fluctuations. Mov Disord. 2000; 15: 164–6

    Article  PubMed  CAS  Google Scholar 

  41. Sandyk R. Treatment of Parkinson’s disease with magnetic fields reduces the requirement for antiparkinsonian medications. Int J Neurosci. 1994; 74: 191–201

    Article  PubMed  CAS  Google Scholar 

  42. Stallibrass C. An evaluation of the Alexander Technique for the management of disability in Parkinson’s disease–a preliminary study. Clin Rehabil. 1997; 11: 8–12

    Article  PubMed  CAS  Google Scholar 

  43. Pacchetti C, et al Active music therapy in Parkinson’s disease: an integrative method for motor and emotional rehabilitation. Psychosomatic Medicine 2000; 62: 386–93

    Google Scholar 

  44. Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology 1999; 52 (3): 626–9

    Article  PubMed  CAS  Google Scholar 

  45. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late case of multiple sclerosis. Lancet 1990; 336: 37–39

    Article  PubMed  CAS  Google Scholar 

  46. Casetta I, Invernizzi M, Granieri E. Multiple sclerosis and dental amalgam: case-control study in Ferrara, Italy. Neuroepidemiology 2001; 20 (2): 134–7

    Article  PubMed  CAS  Google Scholar 

  47. Beenakker EAC, et al. Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production. Neurology 2001; 57 (5): 892

    Article  PubMed  CAS  Google Scholar 

  48. Flesner G, Lindencrona C. The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis. Journal of Advanced Nursing 1999; 29: 1444–1453

    Article  Google Scholar 

  49. Bowling A. Alternative Medicine and Multiple Sclerosis. 2001. Demos Medical Publishing. NY. 66–67

    Google Scholar 

  50. Gilison G, Wright JV, Ballasiotes G. Transdermal histamine in multiple sclerosis: part one–clinical experience. Altern Med Rev 1999; 4: 424–428

    Google Scholar 

  51. Sandyk R. Long-term beneficial effects of weak electromagnetic fields in multiple sclerosis. Int J Neurosci. 1995; 3 (1–2): 45–57

    Article  Google Scholar 

  52. LeFevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics 2000; 105 (4): E46

    Article  PubMed  CAS  Google Scholar 

  53. Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001; 108: 898–905

    Article  PubMed  CAS  Google Scholar 

  54. Vining EPG, Freeman IM et al. A multicenter study of the efficacy of the ketogenic diet. Archives of Neurology 1998; 55: 1433–1437

    Article  PubMed  CAS  Google Scholar 

  55. Best TH, et al. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000; 54: 2328–30

    Article  PubMed  CAS  Google Scholar 

  56. Stewart WA, et al. Acute pancreatitis causing death in a child on the ketogenic diet. Journal Child Neurology. 2001; 16: 633–5

    Article  Google Scholar 

  57. Katyal NG et al. The ketogenic diet in refractory epilepsy: the experience of Children’s Hospital of Pittsburgh. Clinical Pediatrics. 2000; 39: 153–9

    Article  PubMed  CAS  Google Scholar 

  58. Berry-Kravis E, et al. Bruising and the ketogenic diet: evidence for the diet induced changes in platelet function. Annals of Neurology. 2001; 49: 98–103

    Article  PubMed  CAS  Google Scholar 

  59. Peld N, et al. Melatonin effect on seizures in children with severe neurological deficit disorders. Epilepsia. 2001; 42: 1208–9

    Article  Google Scholar 

  60. Sheldon SH. Pro-convulsant effects of oral melatonin in neurological disabled children. Lancet. 1998; 351: 1254

    Article  PubMed  CAS  Google Scholar 

  61. Jenkins JS. The Mozart effect. Journal of the Royal Society of Medicine. 2001; 94: 170–172

    PubMed  CAS  Google Scholar 

  62. van Tulder MW; Cherkin DC; Berman B; Lao L; Koes BW. The effectiveness of acupuncture in the management of acute and chronic low back pain. A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 1999; 24: 1113–23

    Article  PubMed  Google Scholar 

  63. Brosseau L, Milne S, Robinson V, Marchand S, Shea B, Wells G, Tugwell P. Efficacy of TENS for the treatment of chronic low back pain. Spine 2002; 27: 596–603

    Article  PubMed  Google Scholar 

  64. Basford JR; Sheffield CG; Harmsen WS. Laser therapy: a randomized, controlled trial of the effects of low-intensity Nd:YAG laser irradiation on musculoskeletal back pain. Arch Phys Med Rehabil 1999; 80: 647–52

    Article  PubMed  CAS  Google Scholar 

  65. Ghoname EA, Craig WF, White PF, Ahmed HE, Hamza MA, Henderson BN, Gajraj NM, Huber PJ, Gatchel RJ. Percutaneous electrical nerve stimulation for low back pain: a randomized crossover trial. JAMA 1999; 281: 818823

    Google Scholar 

  66. Andersson GBJ, Lucente T, Davis AM, Kappler RE, Lipton JA, Leurgans S. A comparison of osteopathic spinal manipulation with standard care for patients with low back pain. N Engl J Med 1999; 341: 1426–1431

    Article  PubMed  CAS  Google Scholar 

  67. Cherkin DC, Deyo RA, Battle M, Street J, Barlow W. A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. N Engl J Med 1998; 339: 1021–1029

    Article  PubMed  CAS  Google Scholar 

  68. Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med 2000; 109: 9–14

    Article  PubMed  CAS  Google Scholar 

  69. Ernst E. The risk benefit profile of commonly used herbal therapies: ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136: 42–53

    PubMed  Google Scholar 

  70. Tinianow CL; Tinianow TK; Wilcox M. Effects of hyperbaric oxygen on focal brain contusions. Biomed Sci Instrum 2000; 36: 275–81

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Geriatrics, University of Miami School of Medicine, Miami VA, Medical Center (11A), 1201 NW 16th St., 33125, Miami, FL, USA

    E. Paul Cherniack MD

  2. School of Medicine and Dentistry of New Jersey at Newark University Hospital, University of New Jersey-Newark, 150 Bergen Street, 07103, Newark, NJ, USA

    Neil Cherniack PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kaufman, S., Rubin, M. (2003). Complementary and Alternative Medicine in Neurology. In: Cherniack, E.P., Cherniack, N. (eds) Alternative Medicine for the Elderly. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05185-6_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05185-6_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07913-9

  • Online ISBN: 978-3-662-05185-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation